ATC code V20

ATC code V20: Diagnostic agents

ATC code V20
[[File:|frameless|220px|alt=|]]
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

ATC code V20 is a classification used in the Anatomical Therapeutic Chemical Classification System (ATC) to categorize a group of diagnostic agents. The ATC system is maintained by the World Health Organization (WHO) and is used globally to classify drugs and other medical products.

Classification

ATC code V20 falls under the broader category of ATC code V, which is designated for "Various". This category includes a range of products that do not fit into the other main groups of the ATC system. Specifically, V20 is reserved for diagnostic agents, which are substances used to aid in the diagnosis of medical conditions.

Subcategories

The V20 category can be further divided into specific subcategories based on the type of diagnostic agent and its application. These subcategories may include:

• V20A - Imaging agents: These are used in various imaging techniques such as X-ray, MRI, and CT scan to enhance the visibility of internal structures.
• V20B - In vivo diagnostic biologicals: These include agents used in nuclear medicine and other biological tests.
• V20C - Other diagnostic agents: This subcategory includes diagnostic agents that do not fall into the above categories.

Applications

Diagnostic agents classified under ATC code V20 are crucial in modern medicine as they assist healthcare professionals in:

• Identifying the presence and extent of diseases.
• Monitoring the progression of a disease.
• Evaluating the effectiveness of a treatment.

These agents are used in a variety of diagnostic procedures, including but not limited to:

• Radiography
• Ultrasound
• Magnetic Resonance Imaging (MRI)
• Positron Emission Tomography (PET)

Regulation and Safety

The use of diagnostic agents is regulated by health authorities to ensure their safety and efficacy. Before a diagnostic agent can be used clinically, it must undergo rigorous testing and approval processes. The Food and Drug Administration (FDA) in the United States and the European Medicines Agency (EMA) in Europe are examples of regulatory bodies that oversee these processes.

Also see

• ATC code V
• Diagnostic imaging
• Radiopharmaceuticals
• Contrast agent